The efficacy of peginterferon alfa-2a (40 kD) in a large open-label expanded access programme in Eastern Europe

URBÁNEK, Petr; Marián OLTMAN; Ljubomir IVANOVSKI; vratislav ŘEHÁK; Mehmed GRIBAJCEVIC; Diethelm MESSINGER; Andreas TIETZ and Petr HUSA. The efficacy of peginterferon alfa-2a (40 kD) in a large open-label expanded access programme in Eastern Europe. In Hepatitis C 3rd International Conference The third decade and beyond. 2009.

Basic information

Original name

The efficacy of peginterferon alfa-2a (40 kD) in a large open-label expanded access programme in Eastern Europe

Name in Czech

Úspěšnost léčby peginterferonem alfa-2a (40kD) ve velké otevřeném programu rozšířeného přístupu ve východní Evropě.

Authors

URBÁNEK, Petr; Marián OLTMAN; Ljubomir IVANOVSKI; vratislav ŘEHÁK; Mehmed GRIBAJCEVIC; Diethelm MESSINGER; Andreas TIETZ and Petr HUSA

Edition

Hepatitis C 3rd International Conference The third decade and beyond, 2009

---

Other information

Language

English

Type of outcome

Conference abstract

Field of Study

30300 3.3 Health sciences

Country of publisher

Ireland

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Faculty of Medicine

Tags

International impact